NEW YORK, Sept. 6 – In silico drug discovery company Entelos of Menlo Park, Calif., said Thursday it had raised $25 million in a private placement.

Bear Stearns Health Innoventures led the series C round of financing, while Earlybird, Equity4life, and Compaq Computer also invested in the round. Previous investors, including Abingworth Ventures, Boulder Ventures, Brentwood Ventures, Charles River Ventures, and St. Paul Ventures, also reinvested in the company.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.